Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2653409rdf:typepubmed:Citationlld:pubmed
pubmed-article:2653409lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:2653409lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:2653409lifeskim:mentionsumls-concept:C0002874lld:lifeskim
pubmed-article:2653409lifeskim:mentionsumls-concept:C0206061lld:lifeskim
pubmed-article:2653409lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:2653409pubmed:issue4lld:pubmed
pubmed-article:2653409pubmed:dateCreated1989-6-19lld:pubmed
pubmed-article:2653409pubmed:abstractTextData from 547 patients with aplastic anaemia who received bone marrow transplants from HLA-identical siblings were analysed to determine factors associated with the risk of interstitial pneumonia (IPn). IPn developed in 92 patients (17%). 37% of cases were associated with cytomegalovirus infection and 22% with other organisms; in 41% of cases no organism was identified. The case fatality rate was 64%; the mortality rate due to IPn was 11%. In multivariate analysis, four factors were associated with an increased probability of interstitial pneumonia: use of methotrexate rather than cyclosporine after transplantation (relative risk, 2.8; P less than 0.0008); occurrence of moderate to severe acute graft-versus-host disease (relative risk, 2.2; P less than 0.002); inclusion of total body radiation in the pretransplant preparative regimen (relative risk 2.2, P less than 0.004); and patient age greater than 20 (relative risk 1.7, P less than 0.002). The probability of IPn ranged from 4% for patients with none of these adverse risk factors to 51% (relative risk of 13.4) for patients with all four. The incidence of IPn decreased significantly between 1978 and 1985, paralleling a decrease in the use of total body radiation pretransplant for immune suppression and methotrexate post-transplant for prophylaxis against graft-versus-host disease.lld:pubmed
pubmed-article:2653409pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2653409pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2653409pubmed:languageenglld:pubmed
pubmed-article:2653409pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2653409pubmed:citationSubsetIMlld:pubmed
pubmed-article:2653409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2653409pubmed:statusMEDLINElld:pubmed
pubmed-article:2653409pubmed:monthAprlld:pubmed
pubmed-article:2653409pubmed:issn0007-1048lld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:van BekkumD...lld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:GaleR PRPlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:BortinM MMMlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:RimmA AAAlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:WeinerR SRSlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:DickeK AKAlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:RozmanCClld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:RamsayN KNKlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:MasaokaTTlld:pubmed
pubmed-article:2653409pubmed:authorpubmed-author:HorowitzM MMMlld:pubmed
pubmed-article:2653409pubmed:issnTypePrintlld:pubmed
pubmed-article:2653409pubmed:volume71lld:pubmed
pubmed-article:2653409pubmed:ownerNLMlld:pubmed
pubmed-article:2653409pubmed:authorsCompleteYlld:pubmed
pubmed-article:2653409pubmed:pagination535-43lld:pubmed
pubmed-article:2653409pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:meshHeadingpubmed-meshheading:2653409-...lld:pubmed
pubmed-article:2653409pubmed:year1989lld:pubmed
pubmed-article:2653409pubmed:articleTitleRisk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia.lld:pubmed
pubmed-article:2653409pubmed:affiliationDepartment of Medicine, Medical College of Wisconsin, Milwaukee 53226.lld:pubmed
pubmed-article:2653409pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2653409pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2653409pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2653409lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2653409lld:pubmed